A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

NCT04325776 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: AL2846
DRUG: Zoledronic Acid Injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.